Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | USP1 | O94782 | 2/20 | 0.34 |
| ▸ | WDR48 | Q8TAF3 | 2/20 | 0.34 |
| ▸ | BRD4 | O60885 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.30 |
| ▸ | FEN1 | P39748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24310613 | 0.92 | LMNA (0.43) | LMNAHTTUSP1WDR48BRD4 | |
| SCHEMBL24310227 | 0.90 | HTT (0.36) | LMNAHTTBRD4 | |
| SCHEMBL24310084 | 0.89 | LMNA (0.36) | LMNAHTTMAPT | |
| SCHEMBL24310141 | 0.88 | LMNA (0.35) | LMNAHTT | |
| SCHEMBL24310231 | 0.88 | LMNA (0.35) | LMNAHTT | |
| SCHEMBL24310109 | 0.87 | LMNA (0.38) | LMNAHTTBRD4ALOX5APFEN1 | |
| SCHEMBL24310216 | 0.87 | LMNA (0.38) | LMNAHTTBRD4ALOX5APFEN1 | |
| SCHEMBL24310181 | 0.86 | LMNA (0.37) | LMNAHTTMAPT | |
| SCHEMBL24309672 | 0.83 | HTT (0.38) | LMNAHTTMAPTALOX5APFEN1 | |
| SCHEMBL24309661 | 0.82 | LMNA (0.37) | LMNAHTTBRD4ALOX5APFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022076627-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-04-14 | — | — | WO | disclosed |